1H-Indazole, 5-bromo-7-iodo-

1H-Indazole, 5-bromo-7-iodo- Suppliers list
Company Name: Hebei Weite Medical Technology Co., Ltd  Gold
Tel: 13180081292 13180081292
Email: contact@wetogethermed.com
Company Name: Chiba Pharmaceutical Science and technology Co, Ltd.  
Tel: 0531-81313138 13066006660
Email: chibapharm@foxmail.com
Company Name: Shanghai Devinchem Ltd  
Tel: 027-65318838 13646286950
Email: sales@devinchem.com
Company Name: SuZhou ShiYa Biopharmaceuticals, Inc.  
Tel: 0512-0512-52358471 17715136450
Email: sales@shiyabiopharm.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com

1H-Indazole, 5-bromo-7-iodo- manufacturers

1H-Indazole, 5-bromo-7-iodo- Basic information
Product Name:1H-Indazole, 5-bromo-7-iodo-
Synonyms:1H-Indazole, 5-bromo-7-iodo-;5-Bromo-7-iodo-1H-indazole;1-cyclopropyl-4,6-difluoro-5-iodo-1,3-benzodiazole
CAS:953410-86-1
MF:C7H4BrIN2
MW:322.93
EINECS:
Product Categories:
Mol File:953410-86-1.mol
1H-Indazole, 5-bromo-7-iodo- Structure
1H-Indazole, 5-bromo-7-iodo- Chemical Properties
Boiling point 410.4±30.0 °C(Predicted)
density 2.421±0.06 g/cm3(Predicted)
storage temp. Keep in dark place,Sealed in dry,Room Temperature
pka10.78±0.40(Predicted)
AppearanceLight brown to khaki Solid
InChIInChI=1S/C7H4BrIN2/c8-5-1-4-3-10-11-7(4)6(9)2-5/h1-3H,(H,10,11)
InChIKeyGEPPVMLPAUPZTA-UHFFFAOYSA-N
SMILESN1C2=C(C=C(Br)C=C2I)C=N1
Safety Information
MSDS Information
1H-Indazole, 5-bromo-7-iodo- Usage And Synthesis
Synthesis
4-BroMo-2-Methyl-6-iodoaniline

922170-67-0

1H-Indazole, 5-bromo-7-iodo-

953410-86-1

Acetic anhydride (6.209 g, 60.87 mmol) was added slowly and dropwise to a solution of 4-bromo-2-iodo-6-methylaniline (6.31 g, 20.29 mmol) and potassium acetate (2.386 g, 24.35 mmol) in chloroform (100 mL) at 0 °C and under nitrogen protection. The reaction mixture was stirred at room temperature for 1 hour. Subsequently, the reaction system was warmed to 60 °C, tert-butyl nitrite (10.3 g, 0.1 mol) was added and stirred at 60 °C overnight. Upon completion of the reaction, the mixture was diluted with water and extracted with dichloromethane (2 x 100 mL). The organic phases were combined, washed with saturated brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was dissolved in a mixture of methanol and 6N hydrochloric acid (1:1, v/v) and stirred at room temperature for 5 hours. The reaction solution was adjusted to alkaline with 10N aqueous sodium hydroxide and extracted again with dichloromethane (2 x 100 mL). The organic layers were combined, washed with saturated saline, dried over anhydrous sodium sulfate and concentrated under reduced pressure. Finally, the residue was purified by silica gel column chromatography with petroleum ether/ethyl acetate (100:10:1) as eluent to afford 5-bromo-7-iodo-1hydro-indazole (3.73 g, 57.1% yield) as a light yellow solid. lc/ivis (ESI) m/z: 323 (M+H)+.

References[1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 1, p. 334 - 337
[2] Patent: WO2018/160889, 2018, A1. Location in patent: Page/Page column 638; 639; 640
1H-Indazole, 5-bromo-7-iodo- Preparation Products And Raw materials
Raw materials4-BroMo-2-Methyl-6-iodoaniline-->Acetic anhydride-->Potassium Acetate-->tert-Butyl nitrite-->Chloroform
Tag:1H-Indazole, 5-bromo-7-iodo-(953410-86-1) Related Product Information
3-Bromo-6-fluoro (1H)indazole 6-Fluoro-3-iodo (1H)indazole 3-Bromo-5-fluoro (1H)indazole 3-Bromo-5-methyl (1H)indazole 3-Bromo-4-chloro(1H)indazole 3-Bromo-7-nitroindazole 6-AMINO-3-BROMO (1H)INDAZOLE 5-Fluoro-3-iodo-1H-indazole 3-Bromo-5-chloro-1H-indazole 3-Bromo-6-chloro-1H-indazole